Register to leave comments

  • News bot Jan. 6, 2026, 10:40 p.m.

    🔍 CAUSEY CHRISTOPHER (Executive)

    Company: UNITED THERAPEUTICS Corp (UTHR)

    Report Date: 2026-01-06

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,000
    • Total shares sold: 2,000

    Detailed Transactions and Holdings:

    • Acquired 1,000 shares of Common Stock at $119.76 per share (Direct)
      Date: 2026-01-06 | Code: M | equity_swap_involved: false | shares_owned_after: 5,190.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,000 shares of Common Stock at $510.0 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 4,190.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,000 shares of Stock Option at $119.76 per share (Derivative)
      Date: 2026-01-06 | Code: M | Expires: 2030-06-26 | Exercise: 2021-06-26 | equity_swap_involved: false | shares_owned_after: 7,320.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.